T2 Biosystems, Inc. (TTOO)
USD 0.35
(2.88%)
USD 0.35
(2.88%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -50.07 Million USD | 20.98% |
| 2022 | -63.37 Million USD | -18.46% |
| 2021 | -53.49 Million USD | -8.71% |
| 2020 | -49.2 Million USD | 22.03% |
| 2019 | -63.11 Million USD | -23.38% |
| 2018 | -51.15 Million USD | 18.06% |
| 2017 | -62.42 Million USD | -13.91% |
| 2016 | -54.8 Million USD | -21.01% |
| 2015 | -45.29 Million USD | -44.28% |
| 2014 | -31.39 Million USD | -52.3% |
| 2013 | -20.61 Million USD | -42.58% |
| 2012 | -14.45 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -13.53 Million USD | -30.89% |
| 2024 Q2 | -9.24 Million USD | 33.77% |
| 2023 Q1 | -20.03 Million USD | -75.0% |
| 2023 Q4 | -10.34 Million USD | 32.97% |
| 2023 Q3 | -15.42 Million USD | -143.03% |
| 2023 Q2 | -6.34 Million USD | 68.33% |
| 2023 FY | -50.07 Million USD | 20.98% |
| 2022 Q2 | -21.04 Million USD | -16.08% |
| 2022 Q4 | -11.45 Million USD | 39.57% |
| 2022 FY | -63.37 Million USD | -18.46% |
| 2022 Q1 | -18.13 Million USD | -49.32% |
| 2022 Q3 | -18.95 Million USD | 9.97% |
| 2021 Q1 | -10.66 Million USD | -7.58% |
| 2021 Q4 | -12.14 Million USD | 13.02% |
| 2021 Q3 | -13.96 Million USD | -11.92% |
| 2021 FY | -53.49 Million USD | -8.71% |
| 2021 Q2 | -12.47 Million USD | -17.03% |
| 2020 FY | -49.2 Million USD | 22.03% |
| 2020 Q1 | -14.94 Million USD | -6.47% |
| 2020 Q2 | -10.68 Million USD | 28.52% |
| 2020 Q3 | -11.25 Million USD | -5.33% |
| 2020 Q4 | -9.9 Million USD | 11.96% |
| 2019 Q3 | -14.17 Million USD | 9.43% |
| 2019 FY | -63.11 Million USD | -23.38% |
| 2019 Q4 | -14.04 Million USD | 0.92% |
| 2019 Q2 | -15.64 Million USD | -3.3% |
| 2019 Q1 | -15.14 Million USD | 0.01% |
| 2018 Q3 | -10.76 Million USD | 12.63% |
| 2018 FY | -51.15 Million USD | 18.06% |
| 2018 Q1 | -12.91 Million USD | 29.03% |
| 2018 Q2 | -12.32 Million USD | 4.56% |
| 2018 Q4 | -15.14 Million USD | -40.7% |
| 2017 FY | -62.42 Million USD | -13.91% |
| 2017 Q1 | -14.7 Million USD | -1.06% |
| 2017 Q2 | -15.45 Million USD | -5.12% |
| 2017 Q3 | -14.07 Million USD | 8.93% |
| 2017 Q4 | -18.19 Million USD | -29.26% |
| 2016 Q1 | -13.42 Million USD | -11.59% |
| 2016 Q4 | -14.54 Million USD | -13.82% |
| 2016 Q3 | -12.78 Million USD | 8.99% |
| 2016 Q2 | -14.04 Million USD | -4.62% |
| 2016 FY | -54.8 Million USD | -21.01% |
| 2015 Q4 | -12.03 Million USD | -3.33% |
| 2015 Q2 | -10.99 Million USD | -3.54% |
| 2015 Q1 | -10.61 Million USD | -17.0% |
| 2015 FY | -45.29 Million USD | -44.28% |
| 2015 Q3 | -11.64 Million USD | -5.9% |
| 2014 Q1 | -6.92 Million USD | -8.6% |
| 2014 Q3 | -8.09 Million USD | -10.79% |
| 2014 Q4 | -9.07 Million USD | -12.17% |
| 2014 FY | -31.39 Million USD | -52.3% |
| 2014 Q2 | -7.3 Million USD | -5.53% |
| 2013 Q4 | -6.37 Million USD | -37.27% |
| 2013 FY | -20.61 Million USD | -42.58% |
| 2013 Q1 | -4.58 Million USD | 0.0% |
| 2013 Q2 | -5.01 Million USD | -9.48% |
| 2013 Q3 | -4.64 Million USD | 7.42% |
| 2012 FY | -14.45 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Bionano Genomics, Inc. | -232.49 Million USD | 78.461% |
| Prenetics Global Limited | -62.72 Million USD | 20.163% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -3134.948% |
| CareDx, Inc | -190.28 Million USD | 73.683% |
| Exact Sciences Corporation | -204.14 Million USD | 75.47% |
| Exagen Inc. | -23.68 Million USD | -111.393% |
| Inotiv, Inc. | -105.14 Million USD | 52.371% |
| Guardant Health, Inc. | -479.44 Million USD | 89.555% |
| Biodesix, Inc. | -52.14 Million USD | 3.968% |
| BioNexus Gene Lab Corp. | -2.62 Million USD | -1804.762% |
| Precipio, Inc. | -5.85 Million USD | -755.578% |
| iSpecimen Inc. | -11.09 Million USD | -351.165% |
| Natera, Inc. | -434.8 Million USD | 88.483% |
| Aspira Women's Health Inc. | -16.69 Million USD | -200.042% |
| Standard BioTools Inc. | -74.65 Million USD | 32.923% |
| 23andMe Holding Co. | -666.7 Million USD | 92.489% |
| Castle Biosciences, Inc. | -57.46 Million USD | 12.858% |
| Personalis, Inc. | -108.29 Million USD | 53.759% |
| Aclaris Therapeutics, Inc. | -88.48 Million USD | 43.404% |
| Applied DNA Sciences, Inc. | -9.94 Million USD | -403.435% |
| OpGen, Inc. | -32.66 Million USD | -53.288% |
| Myriad Genetics, Inc. | -112 Million USD | 55.288% |
| ICON Public Limited Company | 612.33 Million USD | 108.178% |
| NeoGenomics, Inc. | -87.96 Million USD | 43.074% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -3134.948% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 105.926% |
| RadNet, Inc. | 3.04 Million USD | 1745.105% |
| MDxHealth SA | -43.1 Million USD | -16.188% |
| Psychemedics Corporation | -4.15 Million USD | -1105.513% |
| Illumina, Inc. | -1.16 Billion USD | 95.687% |
| Check-Cap Ltd. | -17.56 Million USD | -185.047% |
| Twist Bioscience Corporation | -208.72 Million USD | 76.008% |
| DarioHealth Corp. | -59.42 Million USD | 15.734% |
| Fulgent Genetics, Inc. | -167.82 Million USD | 70.161% |
| Sera Prognostics, Inc. | -36.24 Million USD | -38.174% |
| ENDRA Life Sciences Inc. | -10.06 Million USD | -397.771% |
| OPKO Health, Inc. | -188.86 Million USD | 73.485% |
| Medpace Holdings, Inc. | 282.81 Million USD | 117.707% |
| Neogen Corporation | -9.42 Million USD | -431.547% |
| Intelligent Bio Solutions Inc. | -10.15 Million USD | -393.041% |
| Prenetics Global Limited | -62.72 Million USD | 20.163% |
| Mainz Biomed B.V. | -26.29 Million USD | -90.438% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -530.93% |
| Trinity Biotech plc | -24.01 Million USD | -108.498% |
| Neuronetics, Inc. | -30.18 Million USD | -65.878% |
| Sotera Health Company | 51.37 Million USD | 197.472% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -530.93% |